Literature DB >> 25070614

[Treatment of diseases acquired abroad].

G-D Burchard1.   

Abstract

Most imported diseases can be well treated-provided the diagnosis is made in due time. For example, only the rapid and correctly performed treatment of falciparum malaria can impede severe complications and save the patient's life. Effective treatments for amebiasis, giardiasis, leishmaniasis and worm diseases are available. However, it has to be mentioned that evidence from clinical trials is often insufficient. Accordingly only few international guidelines for imported diseases exist.

Entities:  

Mesh：

Year:  2014        PMID： 25070614     DOI： 10.1007/s00108-014-3546-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  23 in total

1.  Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients.

Authors:  Carolina Rocio; Valdir Sabbaga Amato; Raphael A Camargo; Felipe F Tuon; Antonio Carlos Nicodemo
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-03       Impact factor: 2.184

Review 2.  Drugs for treating giardiasis.

Authors:  Carlos E Granados; Ludovic Reveiz; Luis G Uribe; Claudia P Criollo
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

3.  [Malaria].

Authors:  G D Burchard
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

4.  Imported enteric fever: case series from the hospital for tropical diseases, London, United Kingdom.

Authors:  Trupti A Patel; Margaret Armstrong; Stephen D Morris-Jones; Stephen G Wright; Tom Doherty
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

Review 5.  Rickettsial infections in the tropics and in the traveler.

Authors:  Lucas S Blanton
Journal:  Curr Opin Infect Dis       Date:  2013-10       Impact factor: 4.915

Review 6.  Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis.

Authors:  Julián Solís García del Pozo; Javier Solera
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

7.  Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.

Authors:  Ploenchan Chetchotisakd; Wirongrong Chierakul; Wipada Chaowagul; Siriluck Anunnatsiri; Kriangsak Phimda; Piroon Mootsikapun; Seksan Chaisuksant; Jiraporn Pilaikul; Bandit Thinkhamrop; Sunchai Phiphitaporn; Wattanachai Susaengrat; Chalongchai Toondee; Surasakdi Wongrattanacheewin; Vanaporn Wuthiekanun; Narisara Chantratita; Janjira Thaipadungpanit; Nicholas P Day; Direk Limmathurotsakul; Sharon J Peacock
Journal:  Lancet       Date:  2013-11-25       Impact factor: 79.321

Review 8.  The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.

Authors:  Gilles Guerrier; Eric D'Ortenzio
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Antibiotics for the treatment of leptospirosis: systematic review and meta-analysis of controlled trials.

Authors:  Jaykaran Charan; Deepak Saxena; Summaiya Mulla; Preeti Yadav
Journal:  Int J Prev Med       Date:  2013-05

10.  GeoSentinel surveillance of illness in returned travelers, 2007-2011.

Authors:  Karin Leder; Joseph Torresi; Michael D Libman; Jakob P Cramer; Francesco Castelli; Patricia Schlagenhauf; Annelies Wilder-Smith; Mary E Wilson; Jay S Keystone; Eli Schwartz; Elizabeth D Barnett; Frank von Sonnenburg; John S Brownstein; Allen C Cheng; Mark J Sotir; Douglas H Esposito; David O Freedman
Journal:  Ann Intern Med       Date:  2013-03-19       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.